California State Teachers Retirement System (CalSTRS)’s Contineum Therapeutics CTNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-783
Closed -$5.46K 3219
2025
Q1
$5.46K Hold
783
﹤0.01% 2902
2024
Q4
$11.5K Buy
783
+363
+86% +$5.75K ﹤0.01% 2815
2024
Q3
$8.04K Sell
420
-83
-17% -$1.59K ﹤0.01% 2942
2024
Q2
$8.86K Buy
+503
New +$8.1K ﹤0.01% 2938

Other funds holding CTNM

California State Teachers Retirement System (CalSTRS)'s CTNM Position: Q2 2025 in Review

California State Teachers Retirement System (CalSTRS) sold out of Contineum Therapeutics (CTNM) in Q2 2025, closing a stake of 783 shares — an estimated $5.46K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in CTNM in Q2 2024 and held it in 4 quarters. The position peaked at $11.5K in Q4 2024. 70 funds tracked by Wall St. Rank hold CTNM as of Q2 2025.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Contineum Therapeutics position as of Q2 2025 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 783 Contineum Therapeutics shares in Q2 2025, an estimated $5.46K.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Contineum Therapeutics in Q2 2024 and held it in 4 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Contineum Therapeutics position peaked at $11.5K in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2025.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2025, filed 14 Aug 2025.